Pictet Asset Management (Switzerland)’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.43M | Sell |
34,525
-2,897
| -8% | -$120K | ﹤0.01% | 939 |
|
|
2023
Q1 | $2.25M | Sell |
37,422
-2,075
| -5% | -$125K | ﹤0.01% | 903 |
|
|
2022
Q4 | $2.9M | Sell |
39,497
-468
| -1% | -$34.3K | ﹤0.01% | 857 |
|
|
2022
Q3 | $3.04M | Buy |
39,965
+574
| +1% | +$43.6K | ﹤0.01% | 829 |
|
|
2022
Q2 | $2.74M | Buy |
39,391
+151
| +0.4% | +$10.5K | ﹤0.01% | 881 |
|
|
2022
Q1 | $3.25M | Buy |
39,240
+554
| +1% | +$45.9K | ﹤0.01% | 889 |
|
|
2021
Q4 | $2.91M | Buy |
38,686
+2,837
| +8% | +$213K | ﹤0.01% | 935 |
|
|
2021
Q3 | $4.17M | Buy |
+35,849
| New | +$4.17M | ﹤0.01% | 870 |
|